Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Non-HDL Cholesterol Explained: What It Is, How to Calculate It and Why It Matters

Non-HDL Cholesterol Explained: What It Is, How to Calculate It and Why It Matters

Non-HDL cholesterol is your total cholesterol minus your HDL cholesterol. What is left is the cholesterol carried by every type of particle that can build plaque, not only LDL.

You can work it out from any standard lipid panel at no extra cost. It is a more dependable guide than LDL cholesterol when your triglycerides are high, because that is when the usual LDL figure is most likely to read too low.

Key takeaways

  • The sum is simple: total cholesterol minus HDL cholesterol.
  • Non-HDL includes LDL plus the remnant particles that an LDL number leaves out.
  • Treatment goals for non-HDL sit 30 mg/dL above the matching LDL cholesterol goal.
  • It works without fasting and stays reliable when triglycerides are raised.
  • ApoB goes one step further by counting particles instead of measuring their cholesterol.

What non-HDL cholesterol includes

Cholesterol travels in several kinds of particle. HDL is the only one not linked to plaque build-up. Everything else is: LDL, the triglyceride-rich particles made by the liver and their remnants, and Lp(a).

LDL cholesterol counts the cholesterol in just one of those groups. Non-HDL cholesterol counts all of them together. When most of your harmful cholesterol is in LDL, the two numbers tell the same story. When a lot of it sits in remnant particles, as happens with high triglycerides, non-HDL catches what LDL misses.

How to calculate it

Take two numbers from your report and subtract.

  • Total cholesterol: 210 mg/dL
  • HDL cholesterol: 50 mg/dL
  • Non-HDL cholesterol: 210 minus 50 = 160 mg/dL

Many labs now print non-HDL on the report. If yours does not, the sum takes a few seconds. Both inputs are measured directly, which is part of the appeal.

You do not need to have fasted. After an ordinary meal, calculated non-HDL cholesterol changes by only about 8 mg/dL on average.1

Why it beats LDL cholesterol when triglycerides are high

On most lab reports LDL cholesterol is not measured. It is estimated with a formula that uses your triglyceride level to guess how much cholesterol sits in non-LDL particles. The standard formula assumes a fixed ratio of 5 between triglycerides and that cholesterol.2

In real blood samples the ratio differs from person to person, and the estimate drifts as triglycerides climb. A study of more than 1.3 million lipid profiles checked the formula against direct measurement. Among samples with triglycerides of 150 to 199 mg/dL and an estimated LDL cholesterol below 70 mg/dL, only 61% were truly below 70 when measured directly.2

In other words, the formula can make LDL look lower than it is, and it does so in the people whose triglycerides are raised. Non-HDL cholesterol avoids the issue because it involves no estimate.

What the numbers mean

There is no single "normal" non-HDL level. The 2026 ACC/AHA guideline restored treatment goals for it and tied them to your risk category.

Risk categoryLDL cholesterol goalNon-HDL cholesterol goal
Borderline or intermediate 10-year riskBelow 100 mg/dLBelow 130 mg/dL
High 10-year riskBelow 70 mg/dLBelow 100 mg/dL
Established cardiovascular disease at very high riskBelow 55 mg/dLBelow 85 mg/dL

In the 2026 guideline, the non-HDL cholesterol goal is set 30 mg/dL above the matching LDL cholesterol goal in each main risk category.3

These are goals for people in whom lowering cholesterol is being pursued. They are not definitions of health for everyone. Your category depends on your age, blood pressure, diabetes status and other factors, which we explain in LDL goals by risk category.

How well it predicts risk

The evidence for non-HDL cholesterol is large and consistent.

In a study that followed 398,846 people in 19 countries, the 30-year rate of cardiovascular events rose from 7.7% in women with the lowest non-HDL cholesterol to 33.7% in women with the highest. In men the range was 12.8% to 43.6%.4 The lowest group had levels below about 100 mg/dL. The highest had levels of about 220 mg/dL or more.

A meta-analysis of 12 studies with 233,455 participants ranked three markers by how strongly they predicted cardiovascular events. ApoB was the strongest, LDL cholesterol the weakest, and non-HDL cholesterol in between.5

The advantage holds on treatment too. In a study of 13,015 people taking statins, those with high non-HDL cholesterol despite low LDL cholesterol had a 78% higher risk of heart attack than those with both low.6

Where non-HDL stops being enough

Non-HDL cholesterol still measures cholesterol, not particles. Two people with the same non-HDL result can have different numbers of particles, because some particles carry more cholesterol than others. Since each particle can enter the artery wall, the count matters.

ApoB measures that count directly. Non-HDL and ApoB usually agree. When they do not, lipid specialists generally treat ApoB as the more precise measure. Think of non-HDL as the best number you can get from a routine panel, and ApoB as the test to add when the picture is unclear.

Non-HDL cholesterol and a Cardio Res-Q assessment

Both Cardio Res-Q assessments measure ApoB, the particle count that non-HDL cholesterol approximates, along with Lp(a), hs-CRP, insulin, glucose and A1c. The Comprehensive Assessment is $775 and the Enhanced Assessment, which adds imaging, is $999.

Non-HDL cholesterol comes from a standard lipid panel, which the program page does not itemize. Ask our team whether one is drawn at your visit. If you have a recent panel from your own doctor, see bringing outside test results. To book, go to the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Is non-HDL cholesterol on my lab report?

Often, yes. Look for a line labeled "non-HDL cholesterol" near the total. If it is not there, subtract your HDL cholesterol from your total cholesterol to get it.

What is a good non-HDL cholesterol level?

It depends on your risk. Guideline goals range from below 130 mg/dL for people at borderline or intermediate risk down to below 85 mg/dL for people with established disease at very high risk. Your clinician can tell you which applies to you.

If I know my non-HDL, do I still need ApoB?

Not always. If your non-HDL cholesterol is clearly low or clearly high, ApoB may not add much. It helps most when triglycerides are high, when you have diabetes or insulin resistance, or when LDL cholesterol is already low on treatment.

Does a high HDL make my non-HDL result better?

A higher HDL lowers the result of the subtraction, but that does not mean HDL is protecting you. What matters is how much cholesterol is left in the particles that build plaque.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Nordestgaard BG, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 2016. PMID 27122601 · doi:10.1093/eurheartj/ehw152↩
  2. Martin SS, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA 2013. PMID 24240933 · doi:10.1001/jama.2013.280532↩
  3. Sabouret P, et al. The 2026 ACC/AHA Dyslipidemia Guideline: A Critical and Transatlantic Perspective on Personalized Lipid Management. Life (Basel) 2026. PMID 42795336 · doi:10.3390/life16091470↩
  4. Brunner FJ, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet 2019. PMID 31810609 · doi:10.1016/S0140-6736(19)32519-X↩
  5. Sniderman AD, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 2011. PMID 21487090 · doi:10.1161/CIRCOUTCOMES.110.959247↩
  6. Johannesen CDL, et al. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. J Am Coll Cardiol 2021. PMID 33736827 · doi:10.1016/j.jacc.2021.01.027↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify